- Home
- TAC vs CPRX Comparison
TAC vs CPRX Comparison
Compare TAC & CPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TAC | CPRX |
|---|---|---|
| Founded | 1909 | 2002 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Electric Utilities: Central | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 3.0B |
| IPO Year | N/A | 2006 |
Fundamental Metrics
Financial Performance| Metric | TAC | CPRX |
|---|---|---|
| Price | $13.47 | $24.01 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 4 |
| Target Price | $21.63 | ★ $33.25 |
| AVG Volume (30 Days) | ★ 1.7M | 1.2M |
| Earning Date | 02-27-2026 | 02-25-2026 |
| Dividend Yield | ★ 1.35% | N/A |
| EPS Growth | N/A | ★ 44.94 |
| EPS | N/A | ★ 1.71 |
| Revenue | ★ $1,783,342,546.00 | $578,196,000.00 |
| Revenue This Year | N/A | $19.98 |
| Revenue Next Year | N/A | $6.96 |
| P/E Ratio | ★ N/A | $14.01 |
| Revenue Growth | N/A | ★ 25.56 |
| 52 Week Low | $7.82 | $19.05 |
| 52 Week High | $17.88 | $26.58 |
Technical Indicators
Market Signals| Indicator | TAC | CPRX |
|---|---|---|
| Relative Strength Index (RSI) | 54.87 | 50.30 |
| Support Level | $13.02 | $23.73 |
| Resistance Level | $13.62 | $24.85 |
| Average True Range (ATR) | 0.55 | 0.82 |
| MACD | 0.08 | -0.05 |
| Stochastic Oscillator | 68.15 | 33.19 |
Price Performance
Historical ComparisonAbout TAC TransAlta Corporation
TransAlta Corp is an independent power producer based in Alberta, Canada. The company operates a diverse and growing fleet of electrical power generation assets in Canada, the United States, and Australia. The company has six reportable segments namely, Hydro, Wind & Solar, Energy Marketing, Gas, Energy Transition segment and Corporate Segment. The company generates the majority of its revenue from the gas segment.
About CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).